PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9788895-5 1998 In this review we consider the relative contribution of oxidative stress to the effects of PTP inhibition by vanadium-based compounds in lymphocytes. Vanadium 109-117 protein tyrosine phosphatase receptor type U Homo sapiens 91-94 26053397-3 2015 We describe the exact mechanism of the effect of vanadium compounds on protein tyrosine phosphatases (PTP), epidermal growth factor receptor (EGFR), PLCgamma, Src, mitogen-activated protein kinase (MAPK) cascades, transcription factor NF-kappaB, the effect on the proteolysis of COX-2 and the activity of cPLA2. Vanadium 49-57 protein tyrosine phosphatase receptor type U Homo sapiens 102-105 35159385-9 2022 Vanadium compounds are well-known PTP inhibitors and AMPK activators. Vanadium 0-8 protein tyrosine phosphatase receptor type U Homo sapiens 34-37